Nā Huahana a me nā Ho'oponopono a Macro & Micro-Test

ʻO ka PCR Fluorescence | Hoʻonui Isothermal | Colloidal Gold Chromatography | Fluorescence Immunochromatography

Nā huahana

  • Laʻana hoʻokuʻu mea hoʻokuʻu (HPV DNA)

    Laʻana hoʻokuʻu mea hoʻokuʻu (HPV DNA)

    Pili ka pahu i ka hoʻomaʻamaʻa mua ʻana o ka laʻana e hoʻāʻo ʻia, no ka maʻalahi o ka hoʻohana ʻana i nā reagents diagnostic in vitro a i ʻole nā ​​mea hana e hoʻāʻo ai i ka analyte. Nucleic Acid Extraction no ka HPV DNA Product Series.

  • Hantaan Virus Nucleic

    Hantaan Virus Nucleic

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka hantavirus hantaan type nucleic acid i nā laʻana serum.

  • Hemoglobin a me Transferrin

    Hemoglobin a me Transferrin

    Hoʻohana ʻia kēia kime no ka ʻike qualitative o ka nui o ka hemoglobin kanaka a me ka transferrin i nā laʻana o ka ʻili kanaka.

  • ʻO Xinjiang Hemorrhagic Fever Virus

    ʻO Xinjiang Hemorrhagic Fever Virus

    Hiki i kēia pahu ke ʻike qualitative o Xinjiang hemorrhagic fever virus nucleic acid i nā laʻana serum o nā poʻe maʻi i manaʻo ʻia me Xinjiang hemorrhagic fever, a hāʻawi i ke kōkua i ka hōʻoia ʻana o nā maʻi me Xinjiang hemorrhagic fever.

  • ʻO ka maʻi maʻi Encephalitis nahele

    ʻO ka maʻi maʻi Encephalitis nahele

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka ululāʻau encephalitis virus nucleic acid i nā laʻana serum.

  • Hoʻohui ʻia ʻo HBsAg a me HCV Ab

    Hoʻohui ʻia ʻo HBsAg a me HCV Ab

    Hoʻohana ʻia ka pahu no ka ʻike kūpono o ka hepatitis B surface antigen (HBsAg) a i ʻole hepatitis C virus antibody i loko o ke kanaka serum, plasma a me ke koko holoʻokoʻa, a he kūpono ia no ke kōkua ʻana i ka hōʻailona o nā maʻi i manaʻo ʻia he maʻi HBV a i ʻole ka nānā ʻana i nā hihia ma nā wahi me ka nui o ka maʻi.

  • ALDH Genetic Polymorphism

    ALDH Genetic Polymorphism

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka ALDH2 gene G1510A polymorphism pūnaewele i loko o ke kanaka peripheral blood genomic DNA.

  • 11 Nā ʻano o ka maʻi maʻi hanu

    11 Nā ʻano o ka maʻi maʻi hanu

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā pathogens respiratory clinical maʻamau i loko o ka sputum kanaka, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonassis maltophilia (BP) parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi maʻi maʻi a i ʻole maʻi koʻikoʻi me nā maʻi maʻi bacterial o ka ʻōpū hanu.Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o nā pathogens respiratory clinical maʻamau i loko o ka sputum kanaka, me Haemophilus influenzae (HI), Streptococcus pneumoniae (SP), Acinetobacter baumannii (ABA), Pseudomonas aeruginosa (PA), Klebsiella Pneumoniae (KPN), Stenotrophomonassis maltophilia (BP) parapertusss (Bpp), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), Legionella pneumophila (Leg). Hiki ke hoʻohana ʻia nā hopena ma ke ʻano he kōkua i ka ʻike ʻana i nā maʻi maʻi maʻi maʻi a i ʻole maʻi koʻikoʻi me nā maʻi maʻi bacterial o ka ʻōpū hanu.

  • Ka hoʻololi ʻana o ke kanaka PML-RARA Fusion Gene

    Ka hoʻololi ʻana o ke kanaka PML-RARA Fusion Gene

    Hoʻohana ʻia kēia kit no ka ʻike qualitative o PML-RARA fusion gene i loko o nā ʻāpana iwi iwi kanaka i vitro.

  • 14 Nā ʻano maʻi hanu i hui ʻia

    14 Nā ʻano maʻi hanu i hui ʻia

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2), ka maʻi Influenza A (IFV A), ka maʻi Influenza B (IFV B), ka maʻi maʻi hanu hanu (RSV), Adenovirus (Adv), metapneumovirus kanaka (hMPV), rhinovirus (Rhv), ʻano maʻi virus Parainfluenza/IV/IV (PIIV) kanaka. (HBoV), Enterovirus (EV), Coronavirus (CoV), Mycoplasma pneumoniae (MP), Chlamydia pneumoniae (Cpn), a me Streptococcus pneumoniae (SP) nucleic acids i loko o ke kanaka oropharyngeal swab a me nasopharyngeal swab samples.

  • Orientia tsutsugamushi

    Orientia tsutsugamushi

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka nucleic acid o Orientia tsutsugamushi i nā laʻana serum.

  • ʻO ka Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin(RIF), Kūʻē (INH)

    ʻO ka Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin(RIF), Kūʻē (INH)

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Mycobacterium tuberculosis DNA i loko o ke kanaka sputum, ka moʻomeheu paʻa (LJ Medium) a me ka moʻomeheu wai (MGIT Medium), ka wai holoi bronchial, a me nā hoʻololi ʻana i ka 507-533 amino acid codon region (81bp, rifampicin resistance determining region) o ka rpoifampicin kūʻē kūʻokoʻa ʻāpana o ka pūnaeʻa o ka rpoifampic as well. i loko o nā kahua mutation nui o Mycobacterium tuberculosis isoniazid resistance.It hāʻawi i ke kōkua i ka hōʻoia o Mycobacterium tuberculosis maʻi, a ia ike i ka nui kū'ē genes o rifampicin a me isoniazid, e kokua i ka hoomaopopo ana i ka lāʻau kū'ē o Mycobacterium tuberculosis maʻi e ka mea maʻi.